We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (unres) Regulatory News (SPSY)

Share Price Information for Spectra (unres) (SPSY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 223.00
Bid: 216.00
Ask: 230.00
Change: 0.00 (0.00%)
Spread: 14.00 (6.481%)
Open: 223.00
High: 223.00
Low: 223.00
Prev. Close: 223.00
SPSY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of share options

31 May 2016 07:00

RNS Number : 6395Z
Spectra Systems Corporation
31 May 2016
 

Spectra Systems Corporation ("Spectra" or "the Company")

Grant of share options

Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication and brand protection technologies, announces that in accordance with the Company's 2007 Incentive Compensation Plan and the recommendation of the Remuneration Committee, the Board yesterday granted options ("Options") over 3,306,689 shares of Common Stock ("Shares") to Directors and Senior Managers of the Company.

Following this Grant of Options, options over a total of 3,524,377 Shares will have been granted since the Company was admitted to trading on AIM on 25 July 2011, representing 7.8 per cent of Spectra's issued shares of common stock.

The Options, which expire on 27 May 2026, have an exercise price of 25 pence per Share.

Vesting of the Options is conditional on the satisfaction of performance conditions, determined by the Remuneration Committee, in respect of the three years ending 31 December 2018.

The grant of the Options is designed to align the interests of key Directors and senior managers of the Company with those of shareholders and to promote the retention of those individuals.

Details of the number of shares over which Options have been granted to Directors of the Company and their resultant interests are set out below:

Name

New Options

Existing Options

Total Options

Total Common Shares

Nabil Lawandy

1,881,063

2,449,229

4,330,292

1,833,570

Douglas Anderson

687,022

1,170,249

1,857,271

11,313

Martin Jaskel

100,000

120,000

220,000

9,960

BJ Penn

100,000

120,000

220,000

-

Donald Stanford

100,000

120,000

220,000

-

Total

2,868,085

3,979,478

6,847,563

1,854,843

 

Martin Jaskel, Chairman of the Remuneration Committee commented: "We believe that this grant of options, which accords with our policy as announced at the time of our IPO in 2011, provides an opportunity for our key players to benefit from significantly growing the value of our company, thereby aligning their interests with shareholders."

Enquiries:

Spectra Systems Corporation

Martin Jaskel, Chairman of the Remuneration Committee Tel: +44 7789 108042

WH Ireland Limited

Chris Fielding (Head of Corporate Finance) Tel: +44 (0) 20 7220 1650

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHDMGFKLGMGVZM
Date   Source Headline
3rd Apr 20247:00 amRNSCertified Circular Polymer Banknote Substrate
27th Mar 20247:00 amRNSAudited results for 12 months ended 31 Dec 2023
13th Mar 20243:07 pmRNSNotice of Results
11th Jan 20247:00 amRNSExercise of Options and Director/PDMR Shareholding
28th Dec 20237:00 amRNSExercise of Options
21st Dec 202312:15 pmRNSCompletion of Acquisition
15th Dec 20234:35 pmRNSExercise of Options and transfer of shares
4th Dec 20237:00 amRNSAcquisition of Cartor Holdings Limited
6th Nov 20234:43 pmRNSTR-1
12th Oct 20237:00 amRNSLargest Central Bank Consumables Order
25th Sep 20237:00 amRNSInterim Results for Six Months Ended 30 June 2023
6th Sep 20237:00 amRNSResults for the 6 months ended 30 June 2023
7th Jul 20236:01 pmRNSRemoval of Regulation S restrictions from shares
26th Jun 20233:22 pmRNSAnnual General Meeting Lack of Quorum
14th Jun 20237:00 amRNSUpdate on Development Contracts
30th May 20237:00 amRNSAppointment of Chief Financial Officer
25th Apr 20237:00 amRNSAdditional Sensor Services Contract Amendment
24th Apr 20237:00 amRNSResignation of Chief Financial Officer
19th Apr 20237:05 amRNSRemoval of Reg S restrictions from common stock
6th Apr 20237:00 amRNSExercise of Options
31st Mar 20235:14 pmRNSRemoval of Reg S restrictions from shares
21st Mar 202311:44 amRNSDividend Record Date
20th Mar 20237:00 amRNSAudited results for year ended 31 December 2022
16th Mar 20234:35 pmRNSExercise of Options
13th Mar 20237:00 amRNSNotice of Results
6th Mar 202310:39 amRNSRemoval of Reg S restrictions from common stock
11th Oct 20226:12 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSContract Amendment to a Central Bank
21st Sep 20227:00 amRNSExercise of Options
12th Sep 20227:05 amRNSAppointment of Non-Executive Director
12th Sep 20227:00 amRNSInterim Results for Six Months Ended 30 June 2022
16th Aug 20227:00 amRNSFirst Banknote Disinfection System Sold
15th Aug 20227:00 amRNSNew Central Bank Contract Amendment
28th Jul 20227:00 amRNSShare Buy-Back
1st Jul 20222:31 pmRNSShare Buy-Back
28th Jun 20227:00 amRNSShare Buy-Back
15th Jun 20227:00 amRNSAdditional Central Bank Development Revenues
14th Jun 20227:00 amRNSAppointment of Chief Financial Officer
13th Jun 20227:00 amRNSUpdate regarding Solaris
13th Jun 20227:00 amRNSAnnual General Meeting Update
25th May 20227:00 amRNSExercise of Options and Director/PDMR Shareholding
20th May 20228:44 amRNSRemoval of Regulation S restrictions from shares
20th May 20228:41 amRNSResignation of Chief Financial Officer
3rd May 20227:00 amRNSPosting of Annual Report & Notice of AGM
6th Apr 20221:36 pmRNSRemoval of Reg S restrictions from common stock
28th Mar 20227:00 amRNSGrant of Share Options
21st Mar 20227:00 amRNSResults twelve months ended 31 December 2021
24th Feb 20227:00 amRNSSpectra Introduces Covert Polymer Substrate
24th Jan 20227:00 amRNSNew contract awards
21st Jan 20227:00 amRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.